Back to Search
GARY BOXER, MD
MD
Child & Adolescent Psychiatry Physician
NPI: 1215972948Individual
Specialties, Licenses & Credentials
Child & Adolescent Psychiatry PhysicianPrimary
Psychiatry & Neurology — Child & Adolescent Psychiatry
Code: 2084P0804X
114302(MO)
Research & Publications (20)
Microdistribution of targeted, fluorescently labeled anti-carcinoembryonic antigen antibody in metastatic colorectal cancer: implications for radioimmunotherapy.
PMID 18451227·Clin Cancer Res·2008
7-preclinical
Predicting response to radioimmunotherapy from the tumor microenvironment of colorectal carcinomas.
PMID 18089820·Cancer Res·2007
7-preclinical
Characterisation and radioimmunotherapy of L19-SIP, an anti-angiogenic antibody against the extra domain B of fibronectin, in colorectal tumour models.
PMID 17519905·Br J Cancer·2007
7-preclinical
A phase I study of single administration of antibody-directed enzyme prodrug therapy with the recombinant anti-carcinoembryonic antigen antibody-enzyme fusion protein MFECP1 and a bis-iodo phenol mustard prodrug.
PMID 17085666·Clin Cancer Res·2006
3-trial
Tumour parameters affected by combretastatin A-4 phosphate therapy in a human colorectal xenograft model in nude mice.
PMID 15763657·Eur J Cancer·2005
7-preclinical
Sustained tumor regression of human colorectal cancer xenografts using a multifunctional mannosylated fusion protein in antibody-directed enzyme prodrug therapy.
PMID 15701872·Clin Cancer Res·2005
7-preclinical
Analysis of the regional uptake of radiolabeled deoxyglucose analogs in human tumor xenografts.
PMID 14734681·J Nucl Med·2004
4-observational
The nonuniformity of antibody distribution in the kidney and its influence on dosimetry.
PMID 12537523·Radiat Res·2003
7-preclinical
A model-based approach for the optimization of radioimmunotherapy through antibody design and radionuclide selection.
PMID 11877753·Cancer·2002
7-preclinical
Synergy between vascular targeting agents and antibody-directed therapy.
PMID 12459381·Int J Radiat Oncol Biol Phys·2002
7-preclinical
Spatial accuracy of 3D reconstructed radioluminographs of serial tissue sections and resultant absorbed dose estimates.
PMID 12433126·Phys Med Biol·2002
7-preclinical
Antibody and radionuclide characteristics and the enhancement of the effectiveness of radioimmunotherapy by selective dose delivery to radiosensitive areas of tumour.
PMID 12020430·Int J Radiat Biol·2002
7-preclinical
Effectiveness of radiolabelled antibodies for radio-immunotherapy in a colorectal xenograft model: a comparative study using the linear--quadratic formulation.
PMID 11304442·Int J Radiat Biol·2001
4-observational
A mouse model for calculating the absorbed beta-particle dose from (131)I- and (90)Y-labeled immunoconjugates, including a method for dealing with heterogeneity in kidney and tumor.
PMID 11418070·Radiat Res·2001
7-preclinical
Eradication of colorectal xenografts by combined radioimmunotherapy and combretastatin a-4 3-O-phosphate.
PMID 11406542·Cancer Res·2001
7-preclinical
Optimizing radioimmunotherapy by matching dose distribution with tumor structure using 3D reconstructions of serial images.
PMID 11776756·Cancer Biother Radiopharm·2001
7-preclinical
Relationship between tumour morphology, antigen and antibody distribution measured by fusion of digital phosphor and photographic images.
PMID 11401028·Cancer Immunol Immunother·2001
7-preclinical
In-vitro uptake of radioactive lipiodol I-131 and I-125 by hepatoblastoma: implications for targeted radiotherapy.
PMID 11727050·Pediatr Surg Int·2001
8-other
A strategy for antitumor vascular therapy by targeting the vascular endothelial growth factor: receptor complex.
PMID 11325835·Cancer Res·2001
7-preclinical
Catalytic activity of an in vivo tumor targeted anti-CEA scFv::carboxypeptidase G2 fusion protein.
PMID 10699932·Int J Cancer·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 300 SE 2ND ST STE 100
LEES SUMMIT, MO 64063 - Phone
- (816) 404-6170
Quick Facts
- NPI
- 1215972948
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile